Monday, November 25, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco ...

Donald Trump's appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences ...

An employee checks equipment at a pharmaceutical plant in Lianyungang, Jiangsu province. GENG YUHE/FOR CHINA DAILY BEIJING -- China has highlighted its commitment to encouraging the long-term ...

Ramaswamy’s primary source of wealth is Roivant Sciences, a biotech company he founded in 2014. His business strategy centers on acquiring and developing overlooked pharmaceuticals, which are then ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) on November 8 and set a price target of $28.00. The company’s shares closed ...

Pharmaceutical executives and public health ... “What president Trump and Bobby Kennedy are describing is a golden age of American medicine, where we are finally going to reverse the chronic ...

Aurobindo Pharma witnessed an 8.6% YoY increase in net profit, reaching Rs 817 crore in Q2 FY25, driven by robust sales in Europe and growth markets. Despite a dip in US formulations revenue, the ...

The pharmaceutical wholesale division delivered "positive sales growth" through net customer wins and improved service levels. Wesfarmers said its digital health had a pleasing year after ...

WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization.

Hyderabad’s Green Pharma City is making rapid strides on the infrastructure development front with preparations underway for industrial setups within a year, Industries and IT Minister D.

When Monica Church was prescribed Ozempic to treat her diabetes in October 2023, she was told it would help ease her symptoms. By Christmas, the 55 year old woman from Michigan was put in the ...